Press "Enter" to skip to content

Psoriasis Drugs Market 2019 Research Methodology, Business Plans, Development Status, and Industry Size & Share Forecast to 2024

Psoriasis Drugs

The “Psoriasis Drugs Market” report 2019 provides a comprehensive analysis of Psoriasis Drugs industry by types, applications, key players and regions. It shows the Psoriasis Drugs market 2019-2024 by production, consumption, supply, gross margin, the revenue of the industry. Additionally, the Psoriasis Drugs market report covers the details of market size, share, and growth rate of the market with respect to regions.

Get a Sample Copy of the Report At – https://www.industryresearch.co/enquiry/request-sample/14099112

Competitor Analysis:

Psoriasis Drugs market includes the following leading manufacturers on the basis of sales, revenue, price, and gross margin.

  • Eli Lilly and Company
  • Pfizer Inc.
  • Johnson and Johnson (Janssen Biotech Inc.)
  • Celgene Corporation
  • Takeda Pharmaceutical Company Limited
  • Stiefel Laboratories Inc.
  • Novartis AG
  • Amgen Inc.
  • Biogen Idec
  • AbbVie Inc.

    Market Overview:

  • The psoriasis drugs market is expected to register a CAGR of 9.3% during the forecast period. The primary factors that are responsible for the growth of this market include the increasing disease burden and demand for psoriasis medicines in emerging economies, the increasing use of combination therapies, and the increase in psoriasis research and pipeline drugs.
  • Among all these factors, one of the factors expected to have a major impact on the market growth is the increasing use of combination therapies. Research is continuing on this combination therapies approach. However, studies conducted suggest that it often eases psoriasis symptoms more effectively than either treatment by themselves. Biologics usually take a while to work. Combining a biologic with a faster-acting systemic drug, such as cyclosporine, is usually much more effective and safer. With faster, longer-lasting results and fewer side effects, requiring lower doses, many doctors are prescribing combination therapies, which is, in turn, expected to drive the psoriasis drugs market. However, factors such as side effects of existing medications may have a negative impact on market growth.

    Psoriasis Drugs market report presents in-depth analysis regarding the development, current trends, industry policies and regulations implemented in each of the geographical region. It includes analysis of upstream raw materials, downstream demand, and current market dynamics. Furthermore, the Psoriasis Drugs market report provides in-depth insight of Psoriasis Drugs industry during 2019-2024.

    Scope of the Report:

  • Psoriasis is a genetic condition which may not be present at birth. This genetic condition may also be triggered by certain environmental and genetic factors. Factors such as the changing lifestyles of people are leading to increased alcohol consumption and smoking, unhealthy diets, and sedentary living, are making people more prone to this condition.

    Inquire or Share Your Questions If Any Before the Purchasing This Report – https://www.industryresearch.co/enquiry/pre-order-enquiry/14099112

    Key Market Trends:

    Interleukin Inhibitors is Expected to Grow with High CAGR in the Forecasted Period

    Interleukin inhibitors may witness the fastest growth during the forecast period, and the factors aiding these Interleukin inhibitors are their improved safety and efficacy when compared to other psoriasis drugs, and their increased adoption among end users. Drugs like Secukinumab, and Ustekinumab, among others, are aiding market growth as the usage of drugs is increasing each year. Another benefit of the IL-mode of therapy is for the patients who are intolerant or contraindicated to TNF-α inhibitor therapy.

    North America Dominates the Market and is Expected to do so in the Forecast Period

    North America currently dominates the market for psoriasis drugs, and it is expected to continue having a stronghold for a few more years. In North America, the United States holds the largest market share. This can be majorly attributed to the increasing prevalence of psoriasis, the presence of favorable government initiatives, the presence of developed healthcare infrastructure, high adoption of therapeutics, and the presence of key drug manufacturers. All these factors are expected to propel the market in the United States.

    Reasons to Buy Psoriasis Drugs Market Report:

    • Analysis of Psoriasis Drugs market including revenues, future growth, market outlook
    • Historical data and forecast of Psoriasis Drugs industry
    • Psoriasis Drugs market report covers regional analysis including growth estimates
    • To analyze the end user markets including growth estimates
    • Profiles on laboratory balance including products, sales/revenues, and market position
    • Includes Psoriasis Drugs market structure, market drivers, opportunities, and restraints.

    Purchase this Report (Price 4250 USD for a Single-User License) – https://www.industryresearch.co/purchase/14099112

    Psoriasis Drugs Market Report Covers the Following Questions:

    • What trends, challenges and barriers are influencing its growth?
    • What is the and regional outlook for Psoriasis Drugs market?
    • Who are the key players, and what are their strategies?
    • What is the status of Psoriasis Drugs status worldwide?
    • What are the Psoriasis Drugs market challenges to market growth? 
    • What are the Psoriasis Drugs market challenges to market growth? 
    • What are the types and applications of Psoriasis Drugs ?
    • What is the market share of each type and application? 

    Detailed TOC of Psoriasis Drugs Market 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Disease Burden and Demand for Psoriasis Medicines in Emerging Economies
    4.2.2 Increasing Use of Combination Therapies
    4.2.3 Increase in Psoriasis Research and Pipeline Drugs
    4.3 Market Restraints
    4.3.1 Adverse Side Effects of Existing Medications
    4.3.2 High Cost of Psoriasis Treatments
    4.3.3 Extensive Drug Development and Approval Process
    4.4 Porter’s Five Force Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Type of Treatment
    5.1.1 Biologic Drugs
    5.1.2 Small Molecule Systemic Drugs
    5.1.3 Tropical Therapies
    5.2 By Mechanism of Action
    5.2.1 TNF Alpha Inhibitors
    5.2.1.1 Etanercept
    5.2.1.2 Certolizumab Pegol
    5.2.1.3 Adalimumab
    5.2.1.4 Infiximab
    5.2.1.5 Golimumab
    5.2.2 PDE4 Inhibitors
    5.2.2.1 Apremilast
    5.2.3 Interleukin Inhibitors
    5.2.3.1 Secukinumab
    5.2.3.2 Ustekinumab
    5.2.3.3 Other Interleukin Inhibitors
    5.2.4 Other Mechanisms of Action
    5.3 By Route of Administration
    5.3.1 Oral
    5.3.2 Parenteral
    5.3.3 Topical
    5.4 Geography
    5.4.1 North America
    5.4.1.1 US
    5.4.1.2 Canada
    5.4.1.3 Mexico
    5.4.2 Europe
    5.4.2.1 Germany
    5.4.2.2 UK
    5.4.2.3 France
    5.4.2.4 Italy
    5.4.2.5 Spain
    5.4.2.6 Rest of Europe
    5.4.3 Asia-Pacific
    5.4.3.1 China
    5.4.3.2 Japan
    5.4.3.3 India
    5.4.3.4 Australia
    5.4.3.5 South Korea
    5.4.3.6 Rest of Asia-Pacific
    5.4.4 Middle East & Africa
    5.4.4.1 GCC
    5.4.4.2 South Africa
    5.4.4.3 Rest of Middle East & Africa
    5.4.5 South America
    5.4.5.1 Brazil
    5.4.5.2 Argentina
    5.4.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Eli Lilly and Company
    6.1.2 Pfizer Inc.
    6.1.3 Johnson and Johnson (Janssen Biotech Inc.)
    6.1.4 Celgene Corporation
    6.1.5 Takeda Pharmaceutical Company Limited
    6.1.6 Stiefel Laboratories Inc.
    6.1.7 Novartis AG
    6.1.8 Amgen Inc.
    6.1.9 Biogen Idec
    6.1.10 AbbVie Inc.

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Electric Bus Market 2019 Evolving Technologies by Size and Share, Key Players Analysis, Sales Revenue, Growth Status, Opportunity Assessment and Business Expansion Plans 2024

    Fighter Aircraft Market 2019 | Market Research by Latest Business Opportunities, Industry Share, Top Manufacturer, and Global Market Insight Forecast to 2024

    Electronic Packaging Market Size, Share – 2019 in-Depth Analysis by Market Size, Share, Key Players, and Regions, Business Expansion Plans Covered Forecast till 2024

    Quantum Dots Market Size, Share – 2019 in-Depth Analysis by Market Size, Share, Key Players, and Regions, Business Expansion Plans Covered Forecast till 2024